Stoke Therapeutics Inc. (STOK) at a glance

Stoke Therapeutics Inc. (STOK) is a Healthcare company. It trades at $30.07. It does not pay a dividend. Vestovix scores it 51/100 overall. Its strongest dimension is Momentum (61/100) and its weakest is Income (40/100).

Price
$30.08
Market cap
n/a
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$11.17 to $40.22
Vestovix Score51/ 100How this works
Value
50
Growth
50
Income
40
Safety
60
Momentum
61